Avid Holdings hopes a UK patent for its heat-sealed lid for blister-packaged drugs will lead to global licensing agreements.Chief executive Jonathan Bobbett said the patent, which has just been granted, had been lodged in other global markets and that the firm was "confident it will be granted in Europe and North America next".
The patented lid enables random perforation to be applied to any blister-packaged drug and is said to avoid damage to the drug on exit.
Avid offers the lid in varying degrees of child resistance that can be produced without altering existing packaging lines.
Two international pharmaceutical manufacturers have already carried out successful tests on the product.
The company is also investigating the possibility of anti-counterfeit measures offered by the lid.
Source: packagingnews
No comments:
Post a Comment